ENZON PHARMACEUTICALS, INC. (13) | Business Operations (2)
- Form of Indemnification Agreement (Filed With SEC on April 26, 2022)
- Amended and Restated Exclusive IP Marketing Agreement, dated as of June 28, 2004, by and between Microment AG and Enzon Pharmaceuticals, Inc (Filed With SEC on February 21, 2019)